Observational analysis reveals bacterial outer membrane vesicles activate immunity in various applications, suggesting their potential in therapeutic innovations.
Bacterial outer membrane vesicles (OMVs) are potent immunomodulators, activating innate and adaptive immunity. Engineered OMVs show promise in vaccines and cancer immunotherapy, linking microbial insights to clinical innovation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: